Deal watch: Neurokinin 3 receptor antagonist revival heats up with Astellas acquisition

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nature reviews. Drug discovery

• Publication date

  2017-05-31

• Fields of study

  Medicine, Business

• Identifiers
  DOI 10.1038/nrd.2017.102PMID 28559557
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Management of Diabetes Mellitus: A Review

  2025cites this paper
• Effectiveness and safety of fezolinetant in alleviating vasomotor symptoms linked to Menopause.: A systematic review and Meta-Analysis.

  2024cites this paper
• Determining the Relationship Between Hot Flushes and LH Pulses in Menopausal Women Using Mathematical Modeling

  2019cites this paper
• Glutamatergic Neurokinin 3 Receptor Neurons in the Median Preoptic Nucleus Modulate Heat-Defense Pathways in Female Mice.

  2019cites this paper
• Treatment of Menopausal Vasomotor Symptoms with Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial.

  2019cites this paper
• Neurokinin 3 Receptor Antagonists Do Not Increase FSH or Estradiol Secretion in Menopausal Women

  2019cites this paper
• Relationship Between Hot Flushes and LH Pulses in Menopausal Women

  2019cites this paper
• Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action

  2018cites this paper
• Drug repurposing: progress, challenges and recommendations

  2018cites this paper
• Neurokinin 3 receptor antagonists for treatment of vasomotor symptoms: a new panacea or just a flash in the pan?

  2018cites this paper
• Menopausal vasomotor symptoms: central triggers, effectors, and new possibilities of pathogenetic therapy

  2018cites this paper
• The 3rd World Conference on Kisspeptin, “Kisspeptin 2017: Brain and Beyond”: Unresolved questions, challenges and future directions for the field

  2018cites this paper